Cardiac Wire #290 July 24, 2025
SCCT25 Top Trends, MI Mix-Ups, and EchoNext
Cardiac Wire #289 July 21, 2025
Polypills’ CVD Potential, Renal Denervation Coverage, and Women’s Hypertension
Cardiac Wire #288 July 17, 2025
Kerendia comes to HF, PREVENT underperforms, and Women’s Hypertension
Cardiac Wire #287 July 14, 2025
CV Deaths are Changing, SAVR Stagnation, and Elderly ACS
Cardiac Wire #286 July 10, 2025
H1’s Top 6 Cardiology Trends and More
Cardiac Wire #285 July 3, 2025
Kardium’s PFA Funds, the BABICORN, and the Work Diet
Cardiac Wire #284 June 30, 2025
A Polymer Mitral Valve Success and More From NYV 2025
Cardiac Wire #283 June 26, 2025
Microplastics Impact CVD, J&J Injunction, and Novo Quits H&H
Cardiac Wire #282 June 23, 2025
Edwards’ Evoque ADEs, Philips’ Angio Recall, and Baby BP
Cardiac Wire #281 June 19, 2025
Lilly Buys Verve, Cold-Triggered AFib, and GLUCOSE
Cardiac Wire #280 June 16, 2025
Abelacimab’s Safety, CABG + Ablation, and UK TAVR Investigation
Cardiac Wire #279 June 12, 2025
BP Triple Polypill, Robot TAVR Explant, and Polymer MVs
Cardiac Wire #278 June 9, 2025
Decreasing PCI Contrast, ECG for AS, and HF is Expensive
Cardiac Wire #277 June 5, 2025
Regeneron Races to GLP-1s, Titanium Hearts, and Breastfeeding vs. ASCVD
Cardiac Wire #276 June 2, 2025
The ABYSS Answers, PPMI’s Risks, and RNAi for Lp(a)
Cardiac Wire #275 May 29, 2025
BSCI Quits TAVR, Major PE CV Acquisition, and Mayo + Corify
Cardiac Wire #274 May 22, 2025
Navitor vs. Sapien, Regeneron Wins Lawsuit, and Pricey GLP-1s
Cardiac Wire #273 May 19, 2025
Wegovy’s Rapid CV Impact, HF Iron Man, and BP Pills in Bed
Cardiac Wire #272 May 15, 2025